Melanoma Genetics

Understanding and biomarking the generic and immunological determinants of melanoma development and patient survival (MELGEN) is a €4M Marie Skłodowska-Curie European Training Network (Melanoma GeneticsETN), funded under Horizon 2020, brings together seven European Universities and five collaborating academic and commercial partners, in the form of 17 Early Stage Researcher PhD training positions for training in melanoma research with the ultimate aim of improving precision medicine for patients with this disease.

Led by Prof Julia Newton Bishop, FMedSci (University of Leeds), who has a long term relationship with the EU through funding of the very successful worldwide GenoMEL consortium funded under the Framework 6 Programme, MELGEN is integrated into both GenoMEL and sister consortium BioGenoME to foster long-term collaborative projects across Europe.


Further Reading

News & Events

See what we’re up to with our latest news and events both in Brussels and in Yorkshire and how you can get involved.


The purpose of the White Rose Brussels Office is long-term strategic positioning of the three White Rose universities to key stakeholders in Brussels to influence EU research policy. The Office also engages in horizon scanning and opportunity spotting in strategic areas of the universities as well as information gathering. The White Rose universities will engage […]

You currently have JavaScript disabled. This site requires JavaScript to be enabled and some functiomns of the site may not be usable or may not look correct until JavaScript is enabled. You can enable JavaScript by following this tutorial.